Oncotelic Advances AI Manufacturing Services

Oncotelic Therapeutics is advancing its AI-powered Good Manufacturing Practice (GMP) services platform, focusing on revenue generation through AI and robotics manufacturing. This initiative positions the company at the intersection of biotechnology and advanced manufacturing technologies. By integrating artificial intelligence and robotics into its GMP processes, Oncotelic aims to enhance efficiency, precision, and scalability in producing complex biological products. The development is geared towards creating new revenue streams and solidifying its role in the specialized manufacturing sector.